SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3AM'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I9G_A_SAMA301_1 (HYPOTHETICAL PROTEIN RV2118C)	3ago	RIBONUCLEASE U2 (Ustilago sphaerogena)	3 / 3	GLU A 62 HIS A 41 ASP A 108	3AM A 115 (-2.9A) 3AM A 115 (-3.8A) 3AM A 115 (-2.9A)	0.68A	1i9gA-3agoA: undetectable	1i9gA-3agoA: 16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 6	ILE A 18 VAL A 26 ILE A 74 ILE A 137	3AM A 338 (-4.5A) 3AM A 338 ( 4.1A) None None	0.81A	1uwhB-3c0iA: 24.6	1uwhB-3c0iA: 25.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EUF_B_LQQB401_1 (CELL DIVISION PROTEIN KINASE 6)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 12	ILE A 18 VAL A 26 LYS A 41 VAL A 75 PHE A 91 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 ( 4.1A) 3AM A 338 (-2.9A) None 3AM A 338 (-3.6A) 3AM A 338 (-4.7A)	0.56A	2eufB-3c0iA: 21.7	2eufB-3c0iA: 28.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 12	ILE A 18 VAL A 26 ALA A 39 PHE A 91 MET A 94 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) 3AM A 338 (-3.6A) None 3AM A 338 (-4.7A)	0.66A	2y7jA-3c0iA: 33.0	2y7jA-3c0iA: 28.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 10	ILE A 18 VAL A 26 ALA A 39 PHE A 91 MET A 94 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) 3AM A 338 (-3.6A) None 3AM A 338 (-4.7A)	0.77A	2y7jB-3c0iA: 32.8	2y7jB-3c0iA: 28.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 10	ILE A 18 VAL A 26 ALA A 39 PHE A 91 MET A 94 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) 3AM A 338 (-3.6A) None 3AM A 338 (-4.7A)	0.73A	2y7jC-3c0iA: 33.0	2y7jC-3c0iA: 28.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 10	ILE A 18 VAL A 26 ALA A 39 PHE A 91 MET A 94 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) 3AM A 338 (-3.6A) None 3AM A 338 (-4.7A)	0.83A	2y7jD-3c0iA: 32.5	2y7jD-3c0iA: 28.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MIY_A_B49A1_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 11	ILE A 18 ALA A 39 LYS A 41 PHE A 91 PHE A 93 MET A 94	3AM A 338 (-4.5A) 3AM A 338 (-3.3A) 3AM A 338 (-2.9A) 3AM A 338 (-3.6A) 3AM A 338 ( 4.6A) None	0.81A	3miyA-3c0iA: 24.3	3miyA-3c0iA: 26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	5 / 9	ILE A 18 ALA A 39 PHE A 91 PHE A 93 MET A 94	3AM A 338 (-4.5A) 3AM A 338 (-3.3A) 3AM A 338 (-3.6A) 3AM A 338 ( 4.6A) None	0.58A	3miyB-3c0iA: 24.0	3miyB-3c0iA: 26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 9	ILE A 18 ALA A 39 PHE A 93 MET A 94 GLY A 96 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 (-3.3A) 3AM A 338 ( 4.6A) None None 3AM A 338 (-4.7A)	1.26A	3miyB-3c0iA: 24.0	3miyB-3c0iA: 26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 9	ILE A 18 ALA A 39 VAL A 75 PHE A 91 PHE A 93 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 (-3.3A) None 3AM A 338 (-3.6A) 3AM A 338 ( 4.6A) 3AM A 338 (-4.7A)	0.60A	3ti1A-3c0iA: 23.9	3ti1A-3c0iA: 28.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KS8_A_B49A701_1 (SERINE/THREONINE-PRO TEIN KINASE PAK 6)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 10	ILE A 18 ALA A 39 VAL A 75 PHE A 93 GLY A 96 LEU A 148	3AM A 338 (-4.5A) 3AM A 338 (-3.3A) None 3AM A 338 ( 4.6A) None 3AM A 338 (-4.7A)	1.14A	4ks8A-3c0iA: 29.9	4ks8A-3c0iA: 29.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 7	ALA A 39 MET A 94 ASP A 98 LEU A 148	3AM A 338 (-3.3A) None None 3AM A 338 (-4.7A)	0.58A	4l9iA-3c0iA: 11.9	4l9iA-3c0iA: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 7	VAL A 26 ALA A 39 MET A 94 LEU A 148	3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) None 3AM A 338 (-4.7A)	0.76A	4l9iA-3c0iA: 11.9	4l9iA-3c0iA: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WA9_B_AXIB9000_1 (TYROSINE-PROTEIN KINASE ABL1)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	7 / 12	VAL A 26 ALA A 39 LYS A 41 PHE A 93 MET A 94 GLY A 96 LEU A 148	3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) 3AM A 338 (-2.9A) 3AM A 338 ( 4.6A) None None 3AM A 338 (-4.7A)	0.89A	4wa9B-3c0iA: 25.5	4wa9B-3c0iA: 25.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_G_SAMG301_1 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	3ago	RIBONUCLEASE U2 (Ustilago sphaerogena)	3 / 3	GLU A 62 HIS A 41 ASP A 108	3AM A 115 (-2.9A) 3AM A 115 (-3.8A) 3AM A 115 (-2.9A)	0.49A	5c0oG-3agoA: undetectable	5c0oG-3agoA: 15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 7	GLY A 19 GLY A 21 VAL A 26 LYS A 41	None None 3AM A 338 ( 4.1A) 3AM A 338 (-2.9A)	0.22A	5izjA-3c0iA: 21.8	5izjA-3c0iA: 28.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 7	GLY A 19 GLY A 21 VAL A 26 LYS A 41	None None 3AM A 338 ( 4.1A) 3AM A 338 (-2.9A)	0.25A	5j5xA-3c0iA: 20.3	5j5xA-3c0iA: 28.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	7 / 12	ILE A 18 GLY A 19 VAL A 26 ALA A 39 VAL A 75 PHE A 91 LEU A 148	3AM A 338 (-4.5A) None 3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) None 3AM A 338 (-3.6A) 3AM A 338 (-4.7A)	0.68A	5l2iA-3c0iA: 7.7	5l2iA-3c0iA: 26.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	7 / 12	ILE A 18 GLY A 19 VAL A 26 ALA A 39 VAL A 75 PHE A 91 LEU A 148	3AM A 338 (-4.5A) None 3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) None 3AM A 338 (-3.6A) 3AM A 338 (-4.7A)	1.12A	5l2tA-3c0iA: 7.8	5l2tA-3c0iA: 26.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	5 / 9	ILE A 18 GLY A 19 VAL A 26 ALA A 39 MET A 94	3AM A 338 (-4.5A) None 3AM A 338 ( 4.1A) 3AM A 338 (-3.3A) None	0.59A	5lw1B-3c0iA: 23.2	5lw1B-3c0iA: 12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE0_A_XINA401_1 (AP2-ASSOCIATED PROTEIN KINASE 1)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	6 / 12	GLU A 16 ALA A 39 VAL A 75 PHE A 93 GLY A 96 LEU A 148	None 3AM A 338 (-3.3A) None 3AM A 338 ( 4.6A) None 3AM A 338 (-4.7A)	0.84A	5te0A-3c0iA: 27.7	5te0A-3c0iA: 27.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_1 (TYROSINE-PROTEIN KINASE ABL1)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 5	VAL A 165 PHE A 93 MET A 94 GLY A 96	None 3AM A 338 ( 4.6A) None None	0.61A	6hd4A-3c0iA: 23.0	6hd4A-3c0iA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_1 (TYROSINE-PROTEIN KINASE ABL1)	3c0i	PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (Homo sapiens)	4 / 6	VAL A 165 PHE A 93 MET A 94 GLY A 96	None 3AM A 338 ( 4.6A) None None	0.64A	6hd4B-3c0iA: 23.2	6hd4B-3c0iA: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_A_AM2A301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3ago	RIBONUCLEASE U2 (Ustilago sphaerogena)	4 / 8	ASP A 84 HIS A 41 GLU A 62 GLU A 49	None 3AM A 115 (-3.8A) 3AM A 115 (-2.9A) 3AM A 115 (-2.8A)	1.03A	6mn4A-3agoA: undetectable	6mn4A-3agoA: 16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_B_AM2B301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3ago	RIBONUCLEASE U2 (Ustilago sphaerogena)	4 / 8	ASP A 84 HIS A 41 GLU A 62 GLU A 49	None 3AM A 115 (-3.8A) 3AM A 115 (-2.9A) 3AM A 115 (-2.8A)	1.11A	6mn4B-3agoA: undetectable	6mn4B-3agoA: 16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_D_AM2D301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3ago	RIBONUCLEASE U2 (Ustilago sphaerogena)	4 / 8	ASP A 84 HIS A 41 GLU A 62 GLU A 49	None 3AM A 115 (-3.8A) 3AM A 115 (-2.9A) 3AM A 115 (-2.8A)	1.06A	6mn4D-3agoA: undetectable	6mn4D-3agoA: 16.86

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1I9G_A_SAMA301_1","HYPOTHETICAL PROTEIN RV2118C","3ago","RIBONUCLEASE U2","Ustilago sphaerogena",3,"GLU A  62;HIS A  41;ASP A 108","3AM A 115 (-2.9A);3AM A 115 (-3.8A);3AM A 115 (-2.9A)","0.68A","1i9gA-3agoA:undetectable",null],["1UWH_B_BAXB1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",4,"ILE A  18;VAL A  26;ILE A  74;ILE A 137","3AM A 338 (-4.5A);3AM A 338 ( 4.1A);None;None","0.81A","1uwhB-3c0iA:24.6","1i9gA-3agoA:16.37"],["2EUF_B_LQQB401_1","CELL DIVISION PROTEIN KINASE 6","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;VAL A  26;LYS A  41;VAL A  75;PHE A  91;LEU A 148","3AM A 338 (-4.5A);3AM A 338 ( 4.1A);3AM A 338 (-2.9A);None;3AM A 338 (-3.6A);3AM A 338 (-4.7A)","0.56A","2eufB-3c0iA:21.7","1uwhB-3c0iA:25.82"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;VAL A  26;ALA A  39;PHE A  91;MET A  94;LEU A 148","3AM A 338 (-4.5A);3AM A 338 ( 4.1A);3AM A 338 (-3.3A);3AM A 338 (-3.6A);None;3AM A 338 (-4.7A)","0.66A","2y7jA-3c0iA:33.0","2eufB-3c0iA:28.07"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;VAL A  26;ALA A  39;PHE A  91;MET A  94;LEU A 148","3AM A 338 (-4.5A);3AM A 338 ( 4.1A);3AM A 338 (-3.3A);3AM A 338 (-3.6A);None;3AM A 338 (-4.7A)","0.77A","2y7jB-3c0iA:32.8","2y7jA-3c0iA:28.54"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;VAL A  26;ALA A  39;PHE A  91;MET A  94;LEU A 148","3AM A 338 (-4.5A);3AM A 338 ( 4.1A);3AM A 338 (-3.3A);3AM A 338 (-3.6A);None;3AM A 338 (-4.7A)","0.73A","2y7jC-3c0iA:33.0","2y7jB-3c0iA:28.54"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;VAL A  26;ALA A  39;PHE A  91;MET A  94;LEU A 148","3AM A 338 (-4.5A);3AM A 338 ( 4.1A);3AM A 338 (-3.3A);3AM A 338 (-3.6A);None;3AM A 338 (-4.7A)","0.83A","2y7jD-3c0iA:32.5","2y7jC-3c0iA:28.54"],["3MIY_A_B49A1_1","TYROSINE-PROTEIN KINASE ITK\/TSK","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;ALA A  39;LYS A  41;PHE A  91;PHE A  93;MET A  94","3AM A 338 (-4.5A);3AM A 338 (-3.3A);3AM A 338 (-2.9A);3AM A 338 (-3.6A);3AM A 338 ( 4.6A);None","0.81A","3miyA-3c0iA:24.3","2y7jD-3c0iA:28.54"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",5,"ILE A  18;ALA A  39;PHE A  91;PHE A  93;MET A  94","3AM A 338 (-4.5A);3AM A 338 (-3.3A);3AM A 338 (-3.6A);3AM A 338 ( 4.6A);None","0.58A","3miyB-3c0iA:24.0","3miyA-3c0iA:26.76"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;ALA A  39;PHE A  93;MET A  94;GLY A  96;LEU A 148","3AM A 338 (-4.5A);3AM A 338 (-3.3A);3AM A 338 ( 4.6A);None;None;3AM A 338 (-4.7A)","1.26A","3miyB-3c0iA:24.0","3miyB-3c0iA:26.76"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;ALA A  39;VAL A  75;PHE A  91;PHE A  93;LEU A 148","3AM A 338 (-4.5A);3AM A 338 (-3.3A);None;3AM A 338 (-3.6A);3AM A 338 ( 4.6A);3AM A 338 (-4.7A)","0.60A","3ti1A-3c0iA:23.9","3miyB-3c0iA:26.76"],["4KS8_A_B49A701_1","SERINE\/THREONINE-PROTEIN KINASE PAK 6","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"ILE A  18;ALA A  39;VAL A  75;PHE A  93;GLY A  96;LEU A 148","3AM A 338 (-4.5A);3AM A 338 (-3.3A);None;3AM A 338 ( 4.6A);None;3AM A 338 (-4.7A)","1.14A","4ks8A-3c0iA:29.9","3ti1A-3c0iA:28.23"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",4,"ALA A  39;MET A  94;ASP A  98;LEU A 148","3AM A 338 (-3.3A);None;None;3AM A 338 (-4.7A)","0.58A","4l9iA-3c0iA:11.9","4ks8A-3c0iA:29.61"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",4,"VAL A  26;ALA A  39;MET A  94;LEU A 148","3AM A 338 ( 4.1A);3AM A 338 (-3.3A);None;3AM A 338 (-4.7A)","0.76A","4l9iA-3c0iA:11.9","4l9iA-3c0iA:21.94"],["4WA9_B_AXIB9000_1","TYROSINE-PROTEIN KINASE ABL1","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",7,"VAL A  26;ALA A  39;LYS A  41;PHE A  93;MET A  94;GLY A  96;LEU A 148","3AM A 338 ( 4.1A);3AM A 338 (-3.3A);3AM A 338 (-2.9A);3AM A 338 ( 4.6A);None;None;3AM A 338 (-4.7A)","0.89A","4wa9B-3c0iA:25.5","4l9iA-3c0iA:21.94"],["5C0O_G_SAMG301_1","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","3ago","RIBONUCLEASE U2","Ustilago sphaerogena",3,"GLU A  62;HIS A  41;ASP A 108","3AM A 115 (-2.9A);3AM A 115 (-3.8A);3AM A 115 (-2.9A)","0.49A","5c0oG-3agoA:undetectable","4wa9B-3c0iA:25.48"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",4,"GLY A  19;GLY A  21;VAL A  26;LYS A  41","None;None;3AM A 338 ( 4.1A);3AM A 338 (-2.9A)","0.22A","5izjA-3c0iA:21.8","5c0oG-3agoA:15.29"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",4,"GLY A  19;GLY A  21;VAL A  26;LYS A  41","None;None;3AM A 338 ( 4.1A);3AM A 338 (-2.9A)","0.25A","5j5xA-3c0iA:20.3","5izjA-3c0iA:28.38"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",7,"ILE A  18;GLY A  19;VAL A  26;ALA A  39;VAL A  75;PHE A  91;LEU A 148","3AM A 338 (-4.5A);None;3AM A 338 ( 4.1A);3AM A 338 (-3.3A);None;3AM A 338 (-3.6A);3AM A 338 (-4.7A)","0.68A","5l2iA-3c0iA:7.7","5j5xA-3c0iA:28.38"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",7,"ILE A  18;GLY A  19;VAL A  26;ALA A  39;VAL A  75;PHE A  91;LEU A 148","3AM A 338 (-4.5A);None;3AM A 338 ( 4.1A);3AM A 338 (-3.3A);None;3AM A 338 (-3.6A);3AM A 338 (-4.7A)","1.12A","5l2tA-3c0iA:7.8","5l2iA-3c0iA:26.49"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",5,"ILE A  18;GLY A  19;VAL A  26;ALA A  39;MET A  94","3AM A 338 (-4.5A);None;3AM A 338 ( 4.1A);3AM A 338 (-3.3A);None","0.59A","5lw1B-3c0iA:23.2","5l2tA-3c0iA:26.49"],["5TE0_A_XINA401_1","AP2-ASSOCIATED PROTEIN KINASE 1","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",6,"GLU A  16;ALA A  39;VAL A  75;PHE A  93;GLY A  96;LEU A 148","None;3AM A 338 (-3.3A);None;3AM A 338 ( 4.6A);None;3AM A 338 (-4.7A)","0.84A","5te0A-3c0iA:27.7","5lw1B-3c0iA:12.42"],["6HD4_A_STIA604_1","TYROSINE-PROTEIN KINASE ABL1","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",4,"VAL A 165;PHE A  93;MET A  94;GLY A  96","None;3AM A 338 ( 4.6A);None;None","0.61A","6hd4A-3c0iA:23.0","5te0A-3c0iA:27.03"],["6HD4_B_STIB602_1","TYROSINE-PROTEIN KINASE ABL1","3c0i","PERIPHERAL PLASMA MEMBRANE PROTEIN CASK","Homo sapiens",4,"VAL A 165;PHE A  93;MET A  94;GLY A  96","None;3AM A 338 ( 4.6A);None;None","0.64A","6hd4B-3c0iA:23.2","6hd4A-3c0iA:15.41"],["6MN4_A_AM2A301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3ago","RIBONUCLEASE U2","Ustilago sphaerogena",4,"ASP A  84;HIS A  41;GLU A  62;GLU A  49","None;3AM A 115 (-3.8A);3AM A 115 (-2.9A);3AM A 115 (-2.8A)","1.03A","6mn4A-3agoA:undetectable","6hd4B-3c0iA:15.41"],["6MN4_B_AM2B301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3ago","RIBONUCLEASE U2","Ustilago sphaerogena",4,"ASP A  84;HIS A  41;GLU A  62;GLU A  49","None;3AM A 115 (-3.8A);3AM A 115 (-2.9A);3AM A 115 (-2.8A)","1.11A","6mn4B-3agoA:undetectable","6mn4A-3agoA:16.86"],["6MN4_D_AM2D301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3ago","RIBONUCLEASE U2","Ustilago sphaerogena",4,"ASP A  84;HIS A  41;GLU A  62;GLU A  49","None;3AM A 115 (-3.8A);3AM A 115 (-2.9A);3AM A 115 (-2.8A)","1.06A","6mn4D-3agoA:undetectable","6mn4B-3agoA:16.86"]]